Quest Diagnostics (DGX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Quest Diagnostics Revenue Highlights


Latest Revenue (Y)

$9.25B

Latest Revenue (Q)

$2.40B

Main Segment (Y)

Diagnostic Information Services Business

Quest Diagnostics Revenue by Period


Quest Diagnostics Revenue by Year

DateRevenueChange
2023-12-31$9.25B-6.38%
2022-12-31$9.88B-8.39%
2021-12-31$10.79B14.32%
2020-12-31$9.44B22.15%
2019-12-31$7.73B2.59%
2018-12-31$7.53B-2.31%
2017-12-31$7.71B2.58%
2016-12-31$7.51B0.29%
2015-12-31$7.49B0.78%
2014-12-31$7.43B4.04%
2013-12-31$7.15B-3.20%
2012-12-31$7.38B-1.70%
2011-12-31$7.51B1.92%
2010-12-31$7.37B-1.16%
2009-12-31$7.46B2.84%
2008-12-31$7.25B8.12%
2007-12-31$6.70B6.96%
2006-12-31$6.27B13.90%
2005-12-31$5.50B7.36%
2004-12-31$5.13B8.20%
2003-12-31$4.74B15.33%
2002-12-31$4.11B13.24%
2001-12-31$3.63B6.04%
2000-12-31$3.42B55.14%
1999-12-31$2.21B51.19%
1998-12-31$1.46B-4.59%
1997-12-31$1.53B-5.42%
1996-12-31$1.62B-

Quest Diagnostics generated $9.25B in revenue during NA 2023, up -6.38% compared to the previous quarter, and up 122.85% compared to the same period a year ago.

Quest Diagnostics Revenue by Quarter

DateRevenueChange
2024-06-30$2.40B1.31%
2024-03-31$2.37B3.41%
2023-12-31$2.29B-0.31%
2023-09-30$2.29B-1.84%
2023-06-30$2.34B0.30%
2023-03-31$2.33B-0.09%
2022-12-31$2.33B-6.15%
2022-09-30$2.49B1.35%
2022-06-30$2.45B-6.05%
2022-03-31$2.61B-4.85%
2021-12-31$2.74B-1.08%
2021-09-30$2.77B8.78%
2021-06-30$2.55B-6.25%
2021-03-31$2.72B-9.39%
2020-12-31$3.00B7.75%
2020-09-30$2.79B52.49%
2020-06-30$1.83B0.27%
2020-03-31$1.82B-5.40%
2019-12-31$1.93B-1.53%
2019-09-30$1.96B0.15%
2019-06-30$1.95B3.28%
2019-03-31$1.89B2.83%
2018-12-31$1.84B-2.65%
2018-09-30$1.89B-1.56%
2018-06-30$1.92B1.86%
2018-03-31$1.88B-2.69%
2017-12-31$1.94B0.26%
2017-09-30$1.93B-0.62%
2017-06-30$1.94B2.32%
2017-03-31$1.90B2.04%
2016-12-31$1.86B-1.27%
2016-09-30$1.89B-1.10%
2016-06-30$1.91B2.31%
2016-03-31$1.86B0.76%
2015-12-31$1.85B-1.65%
2015-09-30$1.88B-2.34%
2015-06-30$1.93B4.68%
2015-03-31$1.84B-2.34%
2014-12-31$1.88B-1.10%
2014-09-30$1.90B0.11%
2014-06-30$1.90B8.93%
2014-03-31$1.75B-0.60%
2013-12-31$1.76B-1.72%
2013-09-30$1.79B-1.58%
2013-06-30$1.82B1.63%
2013-03-31$1.79B5.85%
2012-12-31$1.69B-8.84%
2012-09-30$1.85B-2.90%
2012-06-30$1.91B-1.53%
2012-03-31$1.94B3.04%
2011-12-31$1.88B-1.42%
2011-09-30$1.91B0.17%
2011-06-30$1.90B4.48%
2011-03-31$1.82B-0.14%
2010-12-31$1.82B-2.18%
2010-09-30$1.86B-0.54%
2010-06-30$1.87B3.83%
2010-03-31$1.81B-2.31%
2009-12-31$1.85B-2.58%
2009-09-30$1.90B-0.25%
2009-06-30$1.90B5.19%
2009-03-31$1.81B0.43%
2008-12-31$1.80B-1.44%
2008-09-30$1.83B-0.61%
2008-06-30$1.84B2.98%
2008-03-31$1.78B-

Quest Diagnostics generated $2.40B in revenue during Q2 2024, up 1.31% compared to the previous quarter, and up 102.83% compared to the same period a year ago.

Quest Diagnostics Revenue Breakdown


Quest Diagnostics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Other Segments$276.00M$274.00M---
Diagnostic Information Services Business$8.98B$9.61B---
Routine clinical testing services--$4.29B$3.84B$4.21B
All other services--$294.00M$298.00M$321.00M
Anatomic pathology testing services--$553.00M$482.00M$579.00M
COVID-19 Testing Services--$2.77B$2.72B-
Gene-based and esoteric testing services--$2.88B$2.10B$2.62B

Quest Diagnostics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Diagnostic Information Services Business (97.02%), and Other Segments (2.98%).

Quarterly Revenue by Product

Product/ServiceJun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Diagnostic Information Services Business$2.33B$2.22B$2.23B$2.27B$2.26B$2.27B$2.92B$2.71B$1.76B$1.74B$1.84B$1.88B$1.87B-------
Other Segments-$67.00M$67.00M$70.00M$72.00M$68.00M$80.00M$77.00M$63.00M$78.00M$82.00M$79.00M$81.00M-------
Routine clinical testing and other services------$1.12B$1.10B$1.07B-----------
All other services------$67.00M$69.00M$70.00M$70.00M$71.00M$76.00M$77.00M-------
Anatomic pathology testing services------$149.00M$144.00M$137.00M$145.00M$138.00M$140.00M$130.00M-------
COVID-19 Testing Services------$316.00M$355.00M$599.00M$722.00M$709.00M$511.00M$828.00M-------
Gene-based and esoteric testing services------$835.00M$787.00M$739.00M$906.00M$646.00M$673.00M$653.00M-------
Routine clinical testing services---------$901.00M$1.21B$1.15B$1.03B-------

Quest Diagnostics's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Diagnostic Information Services Business (100.00%).

Quest Diagnostics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
IQVIQVIA$14.98B$3.81B
DGXQuest Diagnostics$9.25B$2.40B
ICLRICON Public Limited Company$8.12B$2.09B
AAgilent$6.83B$1.58B
CRLCharles River Laboratories$4.13B$1.03B
MTDMettler-Toledo$3.79B$946.75M
IDXXIDEXX Laboratories$3.66B$1.00B
WATWaters$2.96B$708.53M
RVTYRevvity$2.75B$691.68M
SHCSotera Health Company$1.05B$276.59M
TWSTTwist Bioscience$245.11M$81.46M

DGX Revenue FAQ


Quest Diagnostics's yearly revenue for 2023 was $9.25B, representing a decrease of -6.38% compared to 2022. The company's yearly revenue for 2022 was $9.88B, representing a decrease of -8.39% compared to 2021. DGX's yearly revenue for 2021 was $10.79B, representing an increase of 14.32% compared to 2020.

Quest Diagnostics's quarterly revenue for Q2 2024 was $2.4B, a 1.31% increase from the previous quarter (Q1 2024), and a 2.52% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.37B, a 3.41% increase from the previous quarter (Q4 2023), and a 1.50% increase year-over-year (Q1 2023). DGX's quarterly revenue for Q4 2023 was $2.29B, a -0.31% decrease from the previous quarter (Q3 2023), and a -1.93% decrease year-over-year (Q4 2022).

Quest Diagnostics's revenue growth rate for the last 3 years (2021-2023) was -14.24%, and for the last 5 years (2019-2023) was 19.75%.

Quest Diagnostics's revenue streams in c 23 are Other Segments, and Diagnostic Information Services Business. Other Segments generated $276M in revenue, accounting 2.98% of the company's total revenue, up 0.73% year-over-year. Diagnostic Information Services Business generated $8.98B in revenue, accounting 97.02% of the company's total revenue, down -6.59% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Quest Diagnostics was Diagnostic Information Services Business. This segment made a revenue of $8.98B, representing 97.02% of the company's total revenue.